» Articles » PMID: 23636171

Raising Awareness of Acute Kidney Injury: a Global Perspective of a Silent Killer

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2013 May 3
PMID 23636171
Citations 303
Authors
Affiliations
Soon will be listed here.
Abstract

Worldwide, acute kidney injury (AKI) is associated with poor patient outcomes. Over the last few years, collaborative efforts, enabled by a common definition of AKI, have provided a description of the epidemiology, natural history, and outcomes of this disease and improved our understanding of the pathophysiology. There is increased recognition that AKI is encountered in multiple settings and in all age groups, and that its course and outcomes are influenced by the severity and duration of the event. The effect of AKI on an individual patient and the resulting societal burden that ensues from the long-term effects of the disease, including development of chronic kidney disease (CKD) and end-stage renal disease (ESRD), is attracting increasing scrutiny. There is evidence of marked variation in the management of AKI, which is, to a large extent, due to a lack of awareness and an absence of standards for prevention, early recognition, and intervention. These emerging data point to an urgent need for a global effort to highlight that AKI is preventable, its course is modifiable, and its treatment can improve outcomes. In this article, we provide a framework of reference and propose specific strategies to raise awareness of AKI globally, with the goal to ultimately improve outcomes from this devastating disease.

Citing Articles

Engineered extracellular vesicles promote the repair of acute kidney injury by modulating regulatory T cells and the immune microenvironment.

Xie L, Zhang K, Pan K, Su X, Zhao X, Li R J Transl Med. 2025; 23(1):304.

PMID: 40065372 PMC: 11895318. DOI: 10.1186/s12967-025-06268-x.


Recovery of kidney function in acute kidney injury.

Patschan D, Stasche F, Erfurt S, Matyukhin I, Ritter O, Safi W J Nephrol. 2025; .

PMID: 40025396 DOI: 10.1007/s40620-025-02220-w.


Acute kidney injury, the present on admission (POA) indicator and sex disparities: observational study of inpatient real-world data in a Swiss tertiary healthcare system. Explorative analysis.

Triep K, Musy S, Simon M, Endrich O BMJ Public Health. 2025; 2(1):e000131.

PMID: 40018148 PMC: 11812744. DOI: 10.1136/bmjph-2023-000131.


The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury.

Sheng Q, Yu Q, Lu S, Yang M, Fan X, Su H Cell Mol Life Sci. 2025; 82(1):86.

PMID: 39985591 PMC: 11846817. DOI: 10.1007/s00018-025-05596-x.


Unexpectedly high rate of unrecognized acute kidney injury and its trend over the past 14 years.

Han L, Li H, Luo L, Ye X, Ren Y, Xu Z Sci Rep. 2025; 15(1):6305.

PMID: 39984512 PMC: 11845613. DOI: 10.1038/s41598-025-88732-8.


References
1.
Srivastava R, Moudgil A, Bagga A, Vasudev A . Hemolytic uremic syndrome in children in northern India. Pediatr Nephrol. 1991; 5(3):284-8. DOI: 10.1007/BF00867477. View

2.
Hsu C, McCulloch C, Fan D, Ordonez J, Chertow G, Go A . Community-based incidence of acute renal failure. Kidney Int. 2007; 72(2):208-12. PMC: 2673495. DOI: 10.1038/sj.ki.5002297. View

3.
Mehta R, Chertow G . Acute renal failure definitions and classification: time for change?. J Am Soc Nephrol. 2003; 14(8):2178-87. DOI: 10.1097/01.asn.0000079042.13465.1a. View

4.
. Summary of Recommendation Statements. Kidney Int Suppl (2011). 2014; 2(1):8-12. PMC: 4089654. DOI: 10.1038/kisup.2012.7. View

5.
Feest T, Round A, Hamad S . Incidence of severe acute renal failure in adults: results of a community based study. BMJ. 1993; 306(6876):481-3. PMC: 1676802. DOI: 10.1136/bmj.306.6876.481. View